Dr Reddy’s Laboratories Ltd ADR
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $76,727,000 | $76,727,000 | $72,148,000 | $68,802,000 |
Gross Profit | 46,344,000 | 46,344,000 | 42,203,000 | 40,368,000 |
EBITDA | 21,711,000 | 21,286,000 | 22,035,000 | |
EBIT | 17,901,000 | 17,516,000 | 18,246,000 | |
Net Income | 13,920,000 | 13,920,000 | 13,789,000 | 14,800,000 |
Net Change In Cash | 76,727,000 | 76,727,000 | 72,148,000 | 68,802,000 |
Free Cash Flow | 2,072,000 | 2,072,000 | -305,000 | 13,987,000 |
Cash | 4,913,000 | 4,913,000 | 7,342,000 | 13,391,000 |
Basic Shares | 166,545 | 166,786 | 166,775 | 166,704 |
Annual Financials
| Values in thousands | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|
Revenue | $279,164,000 | $245,879,000 | $214,391,000 | $189,722,000 |
Gross Profit | 163,607,000 | 202,972,000 | 113,840,000 | 103,077,000 |
EBITDA | 82,574,000 | 108,784,000 | 52,642,000 | 48,858,000 |
EBIT | 67,733,000 | 96,148,000 | 40,818,000 | 36,062,000 |
Net Income | 55,684,000 | 45,067,000 | 23,568,000 | 17,238,000 |
Net Change In Cash | 279,164,000 | 245,879,000 | 214,391,000 | 189,722,000 |
Free Cash Flow | 17,998,000 | 40,009,000 | 9,059,000 | 23,142,000 |
Cash | 7,107,000 | 5,779,000 | 14,852,000 | 14,829,000 |
Basic Shares | 166,708 | 166,382 | 166,338 | 166,316 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | $83.46 |
2024-03-31 | $78.35 |
2023-12-31 | $82.81 |
2023-09-30 | $88.91 |
